Association between timing of zoledronic acid infusion and hip fracture healing in elderly patients.

Randomised control study on association between timing of zoledronic acid infusion and hip fracture healing in patients more than 50 years of age

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018681

Enrollment

300

Registered

2019-04-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M810- Age-related osteoporosis without current pathological fracture

Interventions

Intervention1: Inj zoledronic acid infusion at 1st week: Injection Zoledronic acid 5mg/100ml i.v. slowly over 1 hour at first week of fracture, dosage is once in a year Control Intervention1: Inj Zole

Eligibility

Inclusion criteria

Inclusion criteria: All patients greater then 50yrs age coming to our hospital with inter-trochanteric femur fracture and treated with closed reduction and nailing of femur

Exclusion criteria

Exclusion criteria: patients with hepatic or renal failure patients with history of chronic steroid intake patient with history of malignancy patients with pathological fracture

Design outcomes

Primary

Measure	Time frame
Assessment of fracture healingTimepoint: outcome assessed at end of one year	—

Secondary

Measure	Time frame
To assess the morbidity and mortality associated with Inj. Zoledronic AcidTimepoint: % of complication in 1 year follow-up	—

Countries

India

Contacts

Public ContactDr Harsh Jalan

Ganga Medical Centre and Hospital

orthoram@gmail.com6001732851

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026